BIOFILCHEM.NS BIOFILCHEM NSE
₹35.09
-30.99% 1Y
Market & Price
Market Cap
-
Current Price
₹35.09
High / Low (52W)
₹54.44 / ₹25.79
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
₹-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
4.04%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
₹0.05
EPS (TTM)
₹-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
₹50.96 Cr
Current Assets
₹42.55 Cr
Working Capital
₹10.71 Cr
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
14.28%
Profit 5Y
-7.22%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- Compounding revenue at 14.3% over 5 years.
CONS
- Earnings shrank at -7.2% CAGR over 5 years.
- Trading 35.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in INR.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | - | 14.20 Cr | 8.35 Cr | 6.43 Cr | 13.54 Cr | 85.63 L |
| Cost of Revenue | - | 13.62 Cr | 7.34 Cr | 5.99 Cr | 13.17 Cr | 42.50 L |
| Gross Profit | - | 57.25 L | 1.01 Cr | 44.30 L | 36.96 L | 43.13 L |
| Operating Expenses | - | 36.40 L | 98.69 L | 50.32 L | 32.12 L | 40.24 L |
| Operating Income | - | 20.85 L | 2.48 L | -6.02 L | 4.84 L | 2.89 L |
| EBITDA | - | 33.01 L | 34.39 L | 2.84 Cr | 17.78 L | 17.32 L |
| Interest Expense | - | 98,000 | 67,000 | 93,000 | 1,000 | 5,000 |
| Pretax Income | - | 22.16 L | 25.38 L | 2.76 Cr | 11.17 L | 10.67 L |
| Tax Provision | - | 5.71 L | 5.41 L | 35.15 L | 2.81 L | 2.75 L |
| Net Income | - | 16.46 L | 19.96 L | 2.41 Cr | 8.36 L | 7.92 L |
| Diluted EPS | 0.01 | 0.10 | - | 1.48 | 0.05 | 0.05 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue | 22.38 Cr | 30.04 Cr | 40.04 Cr | 33.40 Cr |
| Cost of Revenue | 19.46 Cr | 27.42 Cr | 37.51 Cr | 30.85 Cr |
| Gross Profit | 2.92 Cr | 2.61 Cr | 2.53 Cr | 2.56 Cr |
| Operating Expenses | 2.02 Cr | 1.87 Cr | 2.11 Cr | 2.09 Cr |
| Operating Income | 90.50 L | 73.86 L | 41.72 L | 46.80 L |
| EBITDA | 1.49 Cr | 1.26 Cr | 1.30 Cr | 1.15 Cr |
| Interest Expense | 3.90 L | 4.19 L | 3.95 L | 3.61 L |
| Pretax Income | 1.01 Cr | 79.30 L | 86.53 L | 73.61 L |
| Tax Provision | 31.65 L | 23.26 L | 15.61 L | 17.83 L |
| Net Income | 69.84 L | 56.04 L | 70.92 L | 55.77 L |
| Diluted EPS | 0.44 | 0.34 | 0.44 | 0.34 |
Compounded Sales Growth
| 5 Years: | 14.28% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -7.22% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -30.99% |
| 6 Months: | -7.80% |
| 3 Months: | +3.33% |
| 1 Month: | +4.25% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | 18.73 Cr | 31.41 Cr | 47.08 Cr | 50.96 Cr |
| Current Assets | 9.31 Cr | 22.35 Cr | 38.41 Cr | 42.55 Cr |
| Cash & Equivalents | 14.50 L | 3.77 L | 2.28 Cr | 25.53 L |
| Inventory | 1.29 Cr | 1.21 Cr | 2.55 Cr | 3.34 Cr |
| Receivables | 7.17 Cr | 20.50 Cr | 33.03 Cr | 38.31 Cr |
| Total Liabilities | 1.89 Cr | 14.10 Cr | 28.88 Cr | 32.18 Cr |
| Current Liabilities | 1.49 Cr | 13.73 Cr | 28.52 Cr | 31.85 Cr |
| Long Term Debt | - | - | - | - |
| Total Debt | 46.47 L | 52.23 L | 43.89 L | 47.13 L |
| Total Equity | 16.84 Cr | 17.30 Cr | 18.20 Cr | 18.78 Cr |
| Shares Outstanding | 1.63 Cr | 1.63 Cr | 1.63 Cr | 1.63 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -21.99 L | -11.18 L | 2.39 Cr | -1.92 Cr |
| Investing Cash Flow | -6.99 L | -1.06 L | -2.29 L | -10.01 L |
| Financing Cash Flow | -58,000 | 1.51 L | -12.49 L | -45,000 |
| Capital Expenditure | -6.99 L | -1.06 L | -2.29 L | -10.01 L |
| Free Cash Flow | -28.98 L | -12.24 L | 2.37 Cr | -2.02 Cr |
| Net Change in Cash | -29.56 L | -10.73 L | 2.25 Cr | -2.03 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Gross Margin % | 13.1% | 8.7% | 6.3% | 7.7% |
| Operating Margin % | 4.0% | 2.5% | 1.0% | 1.4% |
| Net Margin % | 3.1% | 1.9% | 1.8% | 1.7% |
| ROE % | 4.1% | 3.2% | 3.9% | 3.0% |
| ROCE % | 5.3% | 4.2% | 2.2% | 2.4% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BIOFILCHEM
No recent headlines available.